3Ugwumba FO,Ozoemena OF,Okoh AD,et al.Transvesical prostatectomy in the management of benign prostatic hyperplasia in a developing country.Nigerian Journal of Clinical Practice,2014,17(6):797-801. 被引量：1
4Pande S,Hazra A,Kundu AK.Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia:A randomized controlled trial.Indian Journal of Pharmacology,2014,46(6):601-607. 被引量：1
5El-Helbawy MN,Abd-allah MM,Abd-Elbaky TM,et al.Safety and efficacy of bipolar TURP in management of benign prostatic hyperplasia.Menoufia Medical Journal,2015,28(1):225-232. 被引量：1
6RylA,Rotter I,Sojewski M,et al.Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate(TURP)?.International Journal of Environmental Research and Public Health,2015,12(3):3327-3342. 被引量：1
7Said MM,Hassan NS,Schlicht MJ,et al.Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia.Journal of Toxicology and Environmental Health,Part A,2015,78(7):453-465. 被引量：1
